Overview
Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension
Status:
Completed
Completed
Trial end date:
2005-07-01
2005-07-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This trial is designed to study the efficacy of an amlodipine besylate/benazepril treatment regimen versus an amlodipine treatment regimen in the treatment of severe hypertension.Phase:
Phase 4Details
Lead Sponsor:
Novartis PharmaceuticalsTreatments:
Amlodipine
Benazepril
Criteria
Inclusion Criteria:- Diagnosis of severe hypertension
Exclusion Criteria:
- Diastolic blood pressure (DBP) < 60 mm Hg
- Serum potassium < 3.5 or > 5.5 mEq/L in the absence of all potassium supplements
- Refractory hypertension defined as systolic blood pressure (SBP) ≥ 180 mmHg and/or DBP
≥ 110 mmHg and unresponsive to triple-drug regimens
Other protocol-defined exclusion criteria may apply.